Meropenem versus piperacillin/tazobactam with or without immunoglobulin as second-line therapy for febrile neutropenia in pediatric patients
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine,Immunology and Allergy
Reference15 articles.
1. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies
2. Ceftazidime plus amikacin versus ceftazidime plus vancomycin as empiric therapy in febrile neutropenic children with cancer;Viscoli;Rev Infect Dis,1991
3. Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America;Freifeld;Clin Infect Dis,2011
4. Effect of meropenem with or without immunoglobulin as second-line therapy for febrile neutropenia in pediatric patients;Kobayashi;Pediatr Int,2014
5. A prospective randomized trial comparing piperacillin/tazobactam with meropenem as empiric antibiotic treatment of febrile neutropenic children and adolescents with hematologic and malignant disorders;Sano;Pediatric Blood & Cancer,2017
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Epidemiology of acute respiratory viral infections of children with cancer before the COVID-19 pandemic;OSMANGAZİ JOURNAL OF MEDICINE;2023-09-13
2. Comparison of the Efficacy of Piperacillin/Tazobactam and Meropenem, with or without Intravenous Immunoglobulin, as Second-Line Therapy for Febrile Neutropenia: A Prospective, Randomized Study;Clinical Pediatric Hematology-Oncology;2021-10-31
3. Efficacy of liposomal amphotericin against febrile neutropenia in pediatric patients receiving prophylactic voriconazole;Pediatrics International;2021-03-27
4. Differential efficacy of empirical antibiotic therapy for febrile neutropenia in adolescent/young adult (AYA) and child patients;International Journal of Hematology;2018-07-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3